pemetrexed

The drug is prescribed for the treatment of malignant pleural mesothelioma, as well as non-small cell non-squamous lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line therapy).

Form: powder for solution for infusion

ATC: L01BA04

Manufacturer: Hetero Labs Limited

The drug is indicated for the treatment of malignant unresectable pleural mesothelioma, as well as non-small cell non-squamous lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line treatment).

Form: powder for solution for infusion

ATC: L01BA04

Manufacturer: Hetero Labs Limited

The drug is used for the treatment of malignant unresectable pleural mesothelioma (in combination with cisplatin), as well as non-small cell lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line therapy).

Form: concentrate for infusion solution

ATC: L01BA04

Manufacturer: Oncomed Manufacturing A.S. (Manufacturing, primary packaging, quality control)

The drug is prescribed for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (either in combination with cisplatin or as monotherapy for maintenance or second-line treatment).

Form: powder for preparation of concentrate for infusion solution

ATC: L01BA04

Manufacturer: Thymoorganon Pharmazie GmbH

The drug is prescribed for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line therapy).

Form: powder for preparation of concentrate for infusion solution

ATC: L01BA04

Manufacturer: Thymoorganon Pharmazie GmbH

The drug is prescribed for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line treatment).

Form: powder for solution for infusion

ATC: L01BA04

Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))

The drug is prescribed for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line treatment).

Form: powder for solution for infusion

ATC: L01BA04

Manufacturer: Shilpa Medicare Limited (full production cycle; quality control and stability testing (physical and chemical tests))

The drug is used for the treatment of malignant unresectable pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell non-squamous lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line treatment).

Form: powder for solution for infusion

ATC: L01BA04

Manufacturer: Reliance Life Sciences Private Limited

The drug is used for the treatment of malignant pleural mesothelioma (in combination with cisplatin), as well as for the treatment of non-small cell lung cancer (both in combination with cisplatin and as a single agent for maintenance or second-line therapy).

Form: powder for solution for infusion

ATC: L01BA04

Manufacturer: Reliance Life Sciences Private Limited

The drug is used for the treatment of malignant pleural mesothelioma, as well as non-small cell lung cancer (both in combination with cisplatin and as monotherapy in certain cases).

Form: powder for concentrate for infusion solution

ATC: L01BA04

Manufacturer: Eugia Pharma Specialities Limited

The drug is used for the treatment of malignant pleural mesothelioma, as well as non-small cell lung cancer (both in combination with cisplatin and as monotherapy in certain cases).

Form: powder for concentrate for infusion solution

ATC: L01BA04

Manufacturer: Eugia Pharma Specialities Limited